ChiCTR-TRC-14004478
正在进行
/
/
/
2014-04-10
/
/
Elective surgery with potential massive blood loss requiring blood transfusion
圍手術期輸血指征評分（Peri-Operative Transfusion Trigger Score, POTTS）安全性與有效性的多中心，隨機，對照臨床研究
圍手術期輸血指征評分（Peri-Operative Transfusion Trigger Score, POTTS）安全性與有效性的多中心，隨機，對照臨床研究
圍手術期輸血指征評分（Peri-Operative Transfusion Trigger Score, POTTS）安全性與有效性
随机平行对照
其它
Randomized
pen label
Prince of Wales Hospital, Shatin, Hong Kong
/
20
/
2014-02-20
1990-01-01
/
1. Age older than 14 weeks old; 2. Live in an area of altitude shorter than 2500 m most of the time; 3. Estimated intraoperative blood loss more than 1000ml, or more than 20% of total blood volume.；
请登录查看1. Emergency surgery; 2. Patients with physical status of ASA class V or above; 3. Patients with known severe haematological disorders; 4. Patients with known haemaglobinopathy; 5. Acute hypervolemic haemodilution is planned; 6. Patients with known metastatic cancer or more than one neoplasm concurrently; 7. Other conditions that may preclude the patients from the study, such as language barrier, psychiatric disorders, unable to attend research center for follow up; 8. Patients who enrolled to another research study or are taking experimental medication in last 3 months prior to this study; 9. Not suitable for the study, after assessment by the investigators.；
请登录查看Prince of Wales Hospital, Shatin, Hong Kong
/
GMP办公室2026-03-04
抗体圈2026-03-04
上海和誉生物医药科技有限公司2026-03-04
BioArt2026-03-04
药明康德2026-03-04
药明康德2026-03-04
GLP1减重宝典2026-03-03
良医汇肿瘤资讯2026-03-03
良医汇肿瘤资讯2026-03-03
海创药业2026-03-03
400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
川公网安备51019002008863号
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
“坚决打赢禁毒人民战争”专栏 法律法规 | 美、墨、欧盟管制品种
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科 中国医疗人才网 医药招商网
